Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Mexico City
Clinical trial register · Mexico

Clinical Trials in Mexico City, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Mexico and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1585 matching records held by the registry are in this view. Synced 09 Oct 2026, 03:18 UTC
1585
Studies in scope
all four open statuses
715
Recruiting now
open to new participants
254
Lead sponsors
across recruiting studies
Top sites
Mexico City 19 Monterrey 8 Guadalajara 7 San Pedro Garza García 5 Mérida 5
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Trials with a site in Mexico City

19 of 1585 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Mexico
Start
Recruiting
GlaxoSmithKline
Phase 3
420
San Pedro Garza García, Guadajalara, Mexico City
2025-08-11
Recruiting
GlaxoSmithKline
Phase 1/2
451
Tuxtla Gutiérrez, Cuernavaca, Mexico City, San Pedro Garza García
2025-06-11
Recruiting
GlaxoSmithKline
Phase 1/2
305
San Pedro Garza García, Mexico City
2025-03-04
Recruiting
GlaxoSmithKline
Phase 2
393
DF, Mexico City, San Pedro Garza García
2024-09-27
Recruiting
GlaxoSmithKline
Phase 3
440
Chihuahua City, Guadalajara, Mexicali, Mexico City, Mérida, Monterrey
2024-09-11
Active, closed
GlaxoSmithKline
Phase 3
10,212
Chihuahua City, León, Mexico City, Mérida, Monterrey, Oaxaca City, Querétaro, RM Pharmamexico CITY
2024-08-01
Active, closed
GlaxoSmithKline
Phase 3
88
Guadajalara, La Paz BCS, Mexico City, San Luis Potosí City
2024-06-10
Active, closed
GlaxoSmithKline
Phase 4
303
Cuauhtémoc, DF, Guadalajara Jalisco, León, Mexico City, Mérida, Monterrey Nuevo LeOn, San Luis Potosí City
2024-06-06
Recruiting
GlaxoSmithKline
Phase 3
864
Guadajalara, Guadalajara, Mexico City, Monterrey, Oaxaca City
2024-03-21
Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
NCT05878717Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
GlaxoSmithKline
Phase 2/3
300
Chihuahua City, Guadalajara, Mexico City, Mérida, Torreón
2023-09-13
Recruiting
GlaxoSmithKline
Phase 3
892
DF, Guadalajara, Mexico City, Oaxaca City, San Pedro Garza García, Tijuana
2023-08-01
Active, closed
GlaxoSmithKline
Phase 1/2
30
Mexico City
2021-07-29
Active, closed
GlaxoSmithKline
Phase 3
242
Mexico City, Monterrey
2020-07-14
Rows per page Showing 1–19 of 19
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Mexican investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-mexico/city/mexico-city

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Mexico and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,585 studies in total at the last sync on 09 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 19 of those studies with a site in Mexico City that also match the filters currently applied.

How many clinical trials are recruiting in Mexico City?

9 of the 19 studies on this page are recruiting new participants as of the 09 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 10 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Mexico City), 19 studies
PhaseStudiesRecruitingShare
Phase 39547.4%
Phase 1/26231.6%
Phase 2/32110.5%
Phase 2115.3%
Phase 4105.3%

Most active sponsors

Lead sponsors with the most studies (Mexico City)
Lead sponsorStudiesRecruiting
GlaxoSmithKline199
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.